Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.22.2.2
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Accrued Liabilities Current [Abstract]    
External research and preclinical development $ 11,450 $ 8,274
Employee compensation and benefits 6,747 6,344
Professional fees 3,377 953
Facilities and other 139 53
Accrued expenses $ 21,713 $ 15,624